Finding · criterion S2
Where does the order path stop?
30 of the 47 records in the ledger put an eligibility step in front of the order. 13 let a product reach checkout with no evaluation of the buyer, and 4 carry a null. The split is not subtle: every record that gates is a telehealth service, and every record that does not is a research vendor.
Criterion S2, prescription gating is the only one on this Standard that cannot be read off a page. Marketing copy asserting that a clinician reviews every order is recorded under S1; S2 asks whether the order path actually stops. It is recorded by walking that path with dummy data and halting at the first screen that demands intake answers, an account, or payment. 24 of the 47 records carry a basis naming the exact screen the walk reached.
The number, with both denominators
Of the 47 records, 30 pass S2 and 13 fail it. 4 records are excluded from the numerator and named here rather than counted: Behemoth Labz, Peptide Sciences, Pure Rawz, Science.bio. Against the adjusted denominator of 43 checked records, the count is still 30.
By kind: every one of the 30 telehealth services gates the order. None of the 17 research vendors does, 13 of them checked and 4 carrying a null. The criterion therefore separates the two kinds of seller in this ledger without a single exception in either direction. That is worth stating plainly and worth not over-reading: it describes 43 checked records on one date, not the market.
Where each walk stopped
The screen a walk reaches is the finding. A path that stops at a question about height and weight has asked something about the buyer before taking money. A path that stops at an age attestation has asked the buyer to assert something and checked nothing. Both are recorded below in the record's own words.
| Seller | Kind | S2 | The walk stopped at |
|---|---|---|---|
| altRx | Telehealth | PASS | an eligibility intake headed check your eligibility for GLP-1 treatment, before any product or payment screen |
| Biotech Peptides | Research vendor | FAIL | an age and research-use attestation, the only gate offered before the cart |
| Eden | Telehealth | PASS | the first intake question, which asks the reasons for seeking treatment |
| Fella Health | Telehealth | PASS | the eighth intake screen, which demanded a date of birth under a stated minimum age requirement |
| Found | Telehealth | PASS | the eligibility quiz welcome screen, before any price or payment appeared |
| He & She MD | Telehealth | PASS | the first intake screen, which asks about goals, health and lifestyle |
| HealthRX | Telehealth | PASS | the first intake question about the buyer's goal |
| Henry Meds | Telehealth | PASS | the first intake question, which asks the buyer's weight loss goal |
| Hims & Hers | Telehealth | PASS | the first intake question, which asks the buyer's weight loss goal |
| Ivim Health | Telehealth | PASS | the first intake question, which asks where the buyer is in their health journey |
| Leanmeds | Telehealth | PASS | an eligibility intake headed check your eligibility for GLP-1 treatment, before any product or payment screen |
| LifeMD | Telehealth | PASS | the first intake question, which asks what matters to the buyer |
| Limitless Life Nootropics | Research vendor | FAIL | an application for research access, which is not a medical evaluation |
| Loti Labs | Research vendor | FAIL | an account wall whose only qualifying step is a self-certified age and researcher declaration |
| MangoRx | Telehealth | PASS | account creation, which asks for a name and an email address |
| Mochi Health | Telehealth | PASS | the first eligibility question, which asks the buyer's primary weight loss goal |
| Nextmeds | Telehealth | PASS | an eligibility intake headed check your eligibility for GLP-1 treatment, before any product or payment screen |
| OrderlyMeds | Telehealth | PASS | an account-creation screen demanding a name, an email address and a telephone number, after an eligibility verdict |
| Ro | Telehealth | PASS | the first quiz question, which asks which option interests the buyer |
| SnagRx and Embody | Telehealth | PASS | the first intake question, which asks height and weight |
| Sports Technology Labs | Research vendor | FAIL | account registration inside checkout |
| Strut Health | Telehealth | PASS | the medical questions introduction inside checkout |
| TrimRx | Telehealth | PASS | the third intake screen, which demanded identity data before any product selection or payment |
| Trinity Meds | Telehealth | PASS | an eligibility intake headed check your eligibility for GLP-1 treatment, before any product or payment screen |
23 of the 47 records are not in the table above. Most of them record the gate without naming a stopping screen, and 4 of them record no walk at all, because there was no order path to walk. Every one appears in the full roster at the foot of this page with its basis unabridged, and every one is counted in the numbers above.
What a gate is not
A stop is not a safety finding. It establishes that something was asked before an order could complete, and nothing at all about what was done with the answer. Several of the walks stopped at a first question about height and weight, which is a screening question; several stopped at an account-creation or payment screen, which is not. The Standard records both as a pass because both interrupt the purchase, and the basis says which one a reader is looking at so the difference is not lost in the disposition.
Nor does a failure mean a seller broke a rule. A research vendor that lets a product reach checkout is doing what a research-chemical storefront does, and it usually states in its own terms that the product is not for human consumption. What the criterion records is the structural fact underneath: on those 13 records, nothing between the product page and the payment screen asks anything about the person buying. The 13 records that fail are Biotech Peptides, Blue Sky Peptide, Chemyo, Core Peptides, Limitless Life Nootropics, Loti Labs, Modern Aminos, Nootropic Source, Peptide Pros, Simple Peptide, Sports Technology Labs, Swiss Chems, Umbrella Labs.
The criterion beside the claim
S1 records what a seller says about clinician involvement; S2 records what the order path does. Across this ledger 30 of 47 records assert a clinician evaluation and 30 of 47 stop the order for one. The two counts agree, which is the unremarkable outcome and the one worth recording: no record in this ledger claims an evaluation it does not also gate for. A claim and a gate are still different facts, checked in different ways, and the agreement is a finding rather than an assumption.
The pairing matters because the claim is cheap and the gate is not. Any site can print a sentence about licensed providers. Only a site that has built an intake can stop an order with one, and only a walk can tell the two apart. That is why S2 is recorded by walking rather than by reading, and why an unfinished walk is recorded as a null under the same null rules every other criterion uses, never as a failure.
The full roster
Every record in the ledger with its S2 disposition and the basis recorded against it, so the counts above can be repeated from this page.
| Seller | Kind | S2 | What the walk found |
|---|---|---|---|
| altRx | Telehealth | PASS | The order path was walked from the homepage and stopped at an eligibility intake headed check your eligibility for GLP-1 treatment, before any product or payment screen. |
| Behemoth Labz | Research vendor | NOT VERIFIED | An order path did not resolve, because the cart resolves to the homepage and the checkout returns a page headed Checkout Temporarily Unavailable. The check is open. |
| Biotech Peptides | Research vendor | FAIL | The order path was walked from the product page and stopped at an age and research-use attestation, the only gate offered before the cart. |
| Blue Sky Peptide | Research vendor | FAIL | The order path was walked from the semaglutide page at 152.95 dollars and reached a guest checkout gated only by self-certification checkboxes. |
| Care Bare Rx | Telehealth | PASS | Medication ships only if prescribed after an online provider consultation. |
| Chemyo | Research vendor | FAIL | The order path was walked from a value pack at 149.99 dollars to a checkout collecting billing address and payment, gated only by a self-certification of age and training. |
| Core Peptides | Research vendor | FAIL | Products add to cart directly. No evaluation step exists. |
| CoreAge Rx | Telehealth | PASS | A provider approves each prescription; unapproved orders are refunded in full. |
| Direct Meds | Telehealth | PASS | A medical intake precedes any shipment; medication ships only if prescribed. |
| Eden | Telehealth | PASS | The order path was walked from the weight loss page and stopped at the first intake question, which asks the reasons for seeking treatment. |
| Fella Health | Telehealth | PASS | The order path was walked and stopped at the eighth intake screen, which demanded a date of birth under a stated minimum age requirement. |
| Form Health | Telehealth | PASS | The order path was walked from the quiz and reached a health intake asking a first name and a weight-loss motivation, with no product page and no payment field. |
| Found | Telehealth | PASS | The order path was walked and stopped at the eligibility quiz welcome screen, before any price or payment appeared. |
| Gala Health | Telehealth | PASS | Prescriptions issue only if medically appropriate; the site states no guaranteed prescriptions. |
| He & She MD | Telehealth | PASS | The order path was walked and stopped at the first intake screen, which asks about goals, health and lifestyle. |
| HealthRX | Telehealth | PASS | The order path was walked from the offer page and stopped at the first intake question about the buyer's goal. |
| Henry Meds | Telehealth | PASS | The order path was walked from the GLP-1 treatment page and stopped at the first intake question, which asks the buyer's weight loss goal. |
| Hims & Hers | Telehealth | PASS | The order path was walked from the weight loss page and stopped at the first intake question, which asks the buyer's weight loss goal. |
| Ivim Health | Telehealth | PASS | The order path was walked from the home page and stopped at the first intake question, which asks where the buyer is in their health journey. |
| Leanmeds | Telehealth | PASS | The order path was walked from the homepage and stopped at an eligibility intake headed check your eligibility for GLP-1 treatment, before any product or payment screen. |
| LifeMD | Telehealth | PASS | The order path was walked from the weight management page and stopped at the first intake question, which asks what matters to the buyer. |
| Limitless Life Nootropics | Research vendor | FAIL | The order path was walked from the product page and stopped at an application for research access, which is not a medical evaluation. |
| Loti Labs | Research vendor | FAIL | The order path was walked and stopped at an account wall whose only qualifying step is a self-certified age and researcher declaration. |
| MangoRx | Telehealth | PASS | The order path was walked from the product page and stopped at account creation, which asks for a name and an email address. |
| Mochi Health | Telehealth | PASS | The order path was walked from the home page and stopped at the first eligibility question, which asks the buyer's primary weight loss goal. |
| Modern Aminos | Research vendor | FAIL | The order path was walked from the Hexarelin page at 47.60 dollars, the item added to the cart, and checkout then demanded an account login. |
| Nextmeds | Telehealth | PASS | The order path was walked from the homepage and stopped at an eligibility intake headed check your eligibility for GLP-1 treatment, before any product or payment screen. |
| Nootropic Source | Research vendor | FAIL | The order path was walked from the semaglutide page at 90.00 dollars and reached a guest checkout with payment selection and no eligibility step. |
| Oak | Telehealth | PASS | A qualification step and physician review precede any prescription. |
| OrderlyMeds | Telehealth | PASS | The order path was walked and stopped at an account-creation screen demanding a name, an email address and a telephone number, after an eligibility verdict. |
| Peptide Pros | Research vendor | FAIL | The order path was walked from the BPC-157 page to a full guest checkout with bank account entry, and no screen asked about a diagnosis, a prescription, a clinician or an age. |
| Peptide Sciences | Research vendor | NOT VERIFIED | A purchasable storefront did not resolve, because the site announces a voluntary shutdown of operations. The check is open. |
| Pure Rawz | Research vendor | NOT VERIFIED | An order path did not resolve, because the cart and the checkout both resolve to the homepage. The check is open. |
| Remedy Meds | Telehealth | PASS | The order path was walked through nine screens of health questions covering goals, height, weight, pace and eligibility, with no product page and no payment field. |
| Ro | Telehealth | PASS | The order path was walked from the weight loss page and stopped at the first quiz question, which asks which option interests the buyer. |
| Science.bio | Research vendor | NOT VERIFIED | A purchasable storefront did not resolve, because the whole domain now serves a single notice of permanent closure. The check is open. |
| Shed | Telehealth | PASS | The order path was walked and the first screen asked height, weight, date of birth and nine medical history questions, with no product page and no payment field. |
| Simple Peptide | Research vendor | FAIL | The order path was walked from the BPC-157 page, the item added to the cart, and the cart and the checkout then each redirected to an account wall. |
| SnagRx and Embody | Telehealth | PASS | The order path was walked on both storefronts and stopped at the first intake question, which asks height and weight. |
| Sports Technology Labs | Research vendor | FAIL | The order path was walked to a cart holding one item at 56.99 dollars, and it stopped at account registration inside checkout. |
| Strut Health | Telehealth | PASS | The order path was walked from the semaglutide page and stopped at the medical questions introduction inside checkout. |
| Swiss Chems | Research vendor | FAIL | Products add to cart directly. The only gate is an age attestation. |
| Synergy Rx | Telehealth | PASS | Treatment plans issue only if medically approved after evaluation. |
| TrimRx | Telehealth | PASS | The order path was walked and stopped at the third intake screen, which demanded identity data before any product selection or payment. |
| Trinity Meds | Telehealth | PASS | The order path was walked from the homepage and stopped at an eligibility intake headed check your eligibility for GLP-1 treatment, before any product or payment screen. |
| Umbrella Labs | Research vendor | FAIL | The order path was walked from the semaglutide tablet page at 159.99 dollars to a guest checkout collecting billing details, and no screen asked an eligibility question. |
| Zealthy | Telehealth | PASS | The order path was walked and reached a health question about treatment goals, then an account screen, before any product page or payment field. |
Sources
Each source below is the page a walk started from, walked on the date that record carries. No walk was completed to a purchase, and no payment was made on any of them.
- altRx, the page the walk started from
- Biotech Peptides, the page the walk started from
- Blue Sky Peptide, the page the walk started from
- Chemyo, the page the walk started from
- Eden, the page the walk started from
- Fella Health, the page the walk started from
- Form Health, the page the walk started from
- Found, the page the walk started from
- He & She MD, the page the walk started from
- HealthRX, the page the walk started from
- Henry Meds, the page the walk started from
- Hims & Hers, the page the walk started from
- Ivim Health, the page the walk started from
- Leanmeds, the page the walk started from
- LifeMD, the page the walk started from
- Limitless Life Nootropics, the page the walk started from
- Loti Labs, the page the walk started from
- MangoRx, the page the walk started from
- Mochi Health, the page the walk started from
- Modern Aminos, the page the walk started from
- Nextmeds, the page the walk started from
- Nootropic Source, the page the walk started from
- OrderlyMeds, the page the walk started from
- Peptide Pros, the page the walk started from
- Remedy Meds, the page the walk started from
- Ro, the page the walk started from
- Shed, the page the walk started from
- Simple Peptide, the page the walk started from
- SnagRx and Embody, the page the walk started from
- Sports Technology Labs, the page the walk started from
- Strut Health, the page the walk started from
- TrimRx, the page the walk started from
- Trinity Meds, the page the walk started from
- Umbrella Labs, the page the walk started from
- Zealthy, the page the walk started from
Counts are computed from the ledger at build time against Standard v1.1, in the census run stated at the head of this page. A record filed under several storefronts is counted once.
Counts are generated from the ledger at build time, so this page cannot drift from the records it summarizes. Method and null semantics: how checks are performed. This page ranks nothing, recommends nothing, and carries no partner link.
Related findings
How many peptide sellers name the pharmacy that fills the order?A minority. Most sellers substitute a legal category, such as a licensed 503A pharmacy, for a facility a reader could look up in a state board register.
How many storefronts, and how many companies?Fewer companies than storefronts. Several records in the ledger are filed under more than one consumer domain, and one company names every website it operates in a single sentence of its own terms.
How many peptide sellers print a price before the intake form?A large majority. A price printed on a public page is the norm in this ledger, and the records that withhold one are named on the piece, with the withholding sentence quoted.
Where is the seller? Business address disclosure across the ledgerMost records print an address, and the addresses are not alike. Some are an office, some a registered agent's building, some a private mailbox, and a substantial minority print no address on any of the four surfaces read.
Warning letters across the field, and what happened nextA warning letter alleges and does not halt. The lettered entities in this ledger are counted with their denominator, together with how many still trade and how many letters carry a close-out letter on the FDA index.
The state of the Standard, edition 1Eight criteria applied to every record, each reported as its own pass, fail and not-verified count, split between telehealth services and research vendors. No criterion is summed with another, and no record is scored.
Which pharmacies fill the orders, and how many sellers name the same one?Fewer facilities than storefronts. Several sellers that look like separate businesses name the same filling pharmacy, and one facility appears in the ledger under several different spellings, each written by a different seller.
The criterion the licensed services fail and the research vendors passAlmost the whole split runs one way. The sellers operating outside the prescription system publish more laboratory evidence than the licensed services do, with exceptions on both sides named on the page. The split is structural rather than a difference in care, and a certificate is a document about one lot, not an approval.
The question the regulator asked, and whether the record answers itSome answer it and some do not. The letters and the criterion ask the same question, and this piece reports only the dated state of both, because the ledger holds no earlier reading of those pages to compare against.